Form 4/A for ZYME Zymeworks Inc.
Accepted 2022-12-23 00:00:00 ET · period of report 2022-11-10 · accession 0000899243-22-039331 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-12-23 | 2022-11-10 | ZYME | Josephson Neil | Chief Medical Off | M - OptEx | $0.00 | +5,885 | 16.9K | +53% | $0 |
| DA | 2022-12-23 | 2022-11-10 | ZYME | Josephson Neil | Chief Medical Off | S - Sale+OE | $8.10 | -2,475 | 14.4K | -15% | -$20.0K |
| DA | 2022-12-23 | 2022-11-10 | ZYME | Josephson Neil | Chief Medical Off | M - OptEx | $0.00 | -5,885 | 11.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-10 | M | A | 5,885 | $0.00 | 16,924 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-10 | S | D | 2,475 | $8.10 | 14,449 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.09 to $8.10, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Restricted Stock Unit | 2022-11-10 | M | D | 5,885 | $0.00 | 11,772 | D | — · — to — | 5,885 Common Shares | (F4) Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. (F5) The RSUs were granted on November 10, 2021 and vest in three equal annual instalments beginning on November 10, 2022. |